Journal Guide

Medicine(all)Genetics(clinical)Immunology and Allergy Pulmonary and Respiratory Medicine

Founded by The Nordic Respiratory Academy (NORA), The Clinical Respiratory Journal (CRJ) provides a rapid-response forum for publishing clinical research in all areas of respiratory medicine from clinical lung disease to basic research relevant to the clinic. With just 1 month from receipt of manuscript to first decision, CRJ offers a swift, interactive peer-review process. We publish original research, review articles, case studies, editorials and book reviews in all areas of clinical lung disease including:

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Wileyn lehdissä

Open Access Publishing in Wiley Journals

Publisher: Wiley

Genetics Molecular Biology Molecular Medicine Medicine(all)Genetics(clinical)Drug Discovery

The Journal of Gene Medicine publishes high quality original articles and reviews on the science of gene transfer and its applications in gene and cell therapy. Key areas of interest are the design and production of vectors, delivery and targeting, gene expression and regulation, preclinical studies including animal models, developmental aspects and clinical trials. The editors particularly welcome articles dealing with the methodological aspects of gene transfer in vivo, notably in the context of human studies. Papers presenting research into the mechanisms underlying gene transfer; the application and refinement of new technologies such as RNAi, stem cells and allied approaches such as DNA vaccines; or addressing more fundamental biological issues which could lead to more effective gene transfer are also encouraged. Please note that the Journal of Gene Medicine is online-only.

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Wileyn lehdissä

Open Access Publishing in Wiley Journals

Publisher: Routledge

Genetics(clinical)Health Policy Reproductive Medicine Social Sciences(all)

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELib-konsortion sopimus Taylor & Francisin kanssa koskee kaikkia T&F Open Select -lehtiä (eli hybridilehtiä) yhteiskuntatieteellisiltä, humanistisilta ja luonnontieteellisiltä aloilta ja Full OA-lehteä Annals of Medicine. Sopimus sisältää rajallisen määrän avoimesti julkaistavia artikkeleita. Avoimen julkaisemisen oikeus koskee vastaavia kirjoittajia.
The FinELib consortium agreement with Taylor & Francis covers all T&F Open Select journals (i.e., hybrid journals) in the social sciences, humanities, and natural sciences and the full OA journal Annals of Medicine. The agreement includes a limited number of articles that can be published open access. OA publishing option without extra charge applies to corresponding authors.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Taylor & Francisin lehdissä

Open Access Publishing in Taylor & Francis Journals

Visit Publisher homepage Visit journal homepage View aims and scope

Publisher: Cambridge University Press

Genetics(clinical)Obstetrics and Gynaecology Pediatrics, Perinatology, and Child Health

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELib sopimus kattaa vuodelle 2025 Turun yliopistoon affilioituneille vastaaville kirjoittajille lisämaksuttoman ja rajoittamattoman avoimen julkaisemisen CUP:n Full OA- ja hybridilehdissä.
The FinELib agreement for 2025 covers additional cost-free and unlimited open access publishing in CUP's Full OA and hybrid journals for corresponding authors affiliated to University of Turku.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Cambridge University Pressin lehdissä

Open Access Publishing in Cambridge University Press Journals

Publisher: Baishideng Publishing Group

Cell Biology Genetics Molecular Biology Genetics(clinical)Histology

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Publisher: Springer

Genetics Genetics(clinical)Clinical Neurology Cellular and Molecular Neuroscience

Neurogenetics presents research that contributes to better understanding of the genetic basis of normal and abnormal function of the nervous system. The journal publishes findings in humans and other organisms that help explain neurological disease mechanisms, and papers from many fields such as biophysics, cell biology, human genetics, neuroanatomy, neurochemistry, neurology, neuropathology, neurosurgery and psychiatry. Neurogenetics includes Review Articles, Original Articles, Short Communications and Letters to the Editors.

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2024-2025 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.
FinELib consortium’s agreement with Springer Nature for the years 2024-2025 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.

Ohjeita julkaisemiseen FinELibin sivuilla:

Artikkelin julkaiseminen avoimena Springer Compact lehdissä

Open Access Publishing in Springer Compact Journals

Publisher: Nature Research

Genetics Molecular Biology Genetics(clinical)

Loading data ...

Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

There is no agreement between University of Turku and this journal